Miho Oda

ORCID: 0009-0009-1006-9857 · 1 paper in corpus
case-report 2022
Case reports in women's health ·doi:10.1016/j.crwh.2022.e00442

Tamoxifen, a selective estrogen receptor modulator, is widely used as adjunctive therapy for women with breast cancer. However, tamoxifen has an agonistic effect on the endometrium and may be associated with endometrial proliferation, hyper…